Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study
Paul Williams, Thomas Burke, Josephine M. Norquist, Christina Daskalopoulou, Rebecca M. Speck, Ayman Samkari, Sonya Eremenco and Stephen Joel Coons
JTO clinical and research reports, v 3(4), pp 100298-100298
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study
Creators
Paul Williams - IQVIA (France)
Thomas Burke - MSD (Mexico)
Josephine M. Norquist - Merck & Co., Inc., Rahway, NJ, USA (United States)
Christina Daskalopoulou - Patient-Centered Solutions, IQVIA, Athens, Greece
Rebecca M. Speck - Critical Path Institute
Ayman Samkari - MSD (Mexico)
Sonya Eremenco - Critical Path Institute
Stephen Joel Coons - Critical Path Institute
Publication Details
JTO clinical and research reports, v 3(4), pp 100298-100298
Publisher
Elsevier
Resource Type
Journal article
Language
English
Academic Unit
Pediatrics
Web of Science ID
WOS:001137489100009
Scopus ID
2-s2.0-85127276869
Other Identifier
991021838279904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: